Key Players Mentioned in this Report are :
The key findings section included in the report would assist existing market players in expanding their market shares , and new companies in establishing their presence in the global diabetes injection pens market . The report also profiles key players operating in the diabetes injection pens market which are Novo Nordisk A / S , Eli Lilly and Company , AstraZeneca plc , Biocon Ltd ., Sanofi S . A ., Becton , Dickinson and Company , Owen Mumford Ltd ., Jiangsu Delfu Co . and Wockhardt Ltd . The global diabetes injection pens market is dominated by three global vendors that accounts for more than 74 % share of the global market .
The global diabetes injection pens market is segmented as follows :
Global Diabetes Injection Pens Market , by Product Type
� Insulin Pens � Pen Needles
Global Diabetes Injection Pens Market , by Usage
� Reusable Pens � Disposable Pens
Global Diabetes Injection Pens Market , by Distribution Channel
� Hospital Pharmacy � Retail Pharmacy � Online Sales � Diabetes Clinics / Centers